Carregant...
Recent advances in understanding the role of glucagon-like peptide 1
The discovery that glucagon-like peptide 1 (GLP-1) mediates a significant proportion of the incretin effect during the postprandial period and the subsequent observation that GLP-1 bioactivity is retained in type 2 diabetes (T2D) led to new therapeutic strategies being developed for T2D treatment ba...
Guardat en:
| Publicat a: | F1000Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
F1000 Research Limited
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7137394/ https://ncbi.nlm.nih.gov/pubmed/32269764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.20602.1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|